News
CBM2 Student to Attend KUMC OTD Program
CBM2 undergraduate student Shalee Mog is graduating from KU this spring with a major in Microbiology and minor in Spanish! Shalee will be attending the University of Kansas Medical Center (KUMC) next year for the Doctor of Occupational Therapy (OTD) program. ...
CBM2 & BioFluidica researchers work on next generation CTC isolation and analysis platform
CBM2 researchers are working with investigators at BioFluidica to build the next generation CTC isolation and analysis platform. The platform uses a modular microfluidic cartridge that interfaces to instrumentation to enumerate the selected CTCs using either electrical or fluorescence imaging capabilities. ...
Kansasalumni Article Highlights Dr. Soper and Team Work on COVID-19 Test
Reprinted with permission from kansasalumni. ...
Hall Conducts Webinar
Webinar providing a foundation in solid-state nanopore technology, including the original of signals in the platforms (and factors that impact them), pros and cons of the different fabrication techniques used to make them, and the most exciting applications they are being developed towards. ...
Dr. Steve Soper receives a Higuchi-KU Endowment Research Achievement Award
Foundation Distinguished Professor and director of the Center of BioModular Multi-Scale Systems for Precision Medicine Dr. Steve Soper was one of four KU Faculty to receive a Higuchi-KU Endowment Research Achievement Award. Dr. Soper was honored with the Irvin Youngberg Award in Applied Sciences and has received this award for...
CBM2 Team Publishes Research Results
CBM2 Team published their research results in a peer reviewed journal Small, October 2021, ...
CBM2 Secures $6.0M NIH Funding for 5 More Years
The Center of BioModular Multi-Scale Systems for Precision Medicine (CBM2) proudly announces the renewal of its $6.0 million NIH funding for the next 5 years. As one of 50 National Biotechnology Resource Centers (P41 Centers), CBM2 uniquely stands as the sole P41 Center within an NIH Institutional Development Awards (IDeA)...
CBM2 Renewed
CBM2 was recently renewed for funding through the National Institutes of Health, NIH (National Institute of Biomedical Imaging and Bioengineering; NIBIB; $6.0M over 5 years) as a National Biotechnology Resource Center (P41 Center). ...
CBM2 Publishes New Research in ACS Sensors, August 2021
New research from CBM2 was published in ACS Sensors in August 2021, titled, “Tailoring Thermoplastic In-Plane Nanopore Size by Thermal Fusion Bonding for the Analysis of Single Molecules.” Authors of the paper are Uditha S. Athapattu, Chathurika Rathnayaka, Swarnagowri Vaidyanathan, Sachindra S. T. Gamage, Junseo Choi, Ramin Riahipour, Anishkumar Manoharan,...
Review Paper Published in Annual Review of Analytical Chemistry
Researchers from the Center’s Soper group at the University of Kansas published a review paper in the June 2021 14th Volume of Annual Review of Analytical Chemistry. The paper is titled, “Analytical Technologies for Liquid Biopsy of Subcellular Materials.” Authors of the review are Camila D.M. Campos, Katie Childers, Sachindra...
CBM2 Researcher Takes Position at Cepheid
Thilanga N. Pahattuge, CBM2 graduate student from the Soper research group at the University of Kansas, graduated in May 2021 and joined molecular diagnosis company Cepheid in the position of Scientist I-Oncology. At Cepheid, Dr. Pahattuge will be developing novel molecular-based assays for the diagnosis and monitoring of various cancer...
New Paper Published in ACS Sensors
Center researchers published a paper titled, “System Modularity Chip for Analysis of Rare Targets (SMART-Chip): Liquid Biopsy Samples” which appeared in the ACS Sensors journal in May 2021. Authors of the paper include Thilanga N. Pahattuge, Ian M. Freed, Mateusz L. Hupert, Swarnagowri Vaidyanathan, Katie Childers, Malgorzata A. Witek, Kumuditha...
CBMM Researcher Joins Sandia National Laboratories
Swarnagowri Vaidyanathan, a 2021 graduate from the Bioengineering program at the University of Kansas, accepted a postdoctoral position at the Sandia National Laboratories for Joint BioEnergy Institute. Located in Emeryville, CA, Dr. Vaidyanathan will be working on microfluidic technologies to build automated systems for techniques such as CRISPR, Electroporation, and...
CBM2 Publishes Paper in March 2021 Lab on a Chip
CBM2 researchers published a paper in the March 2021 issue of Lab on a Chip titled, “Thermoplastic nanofluidic devices for identifying abasic sites in single DNA molecules.” Authors of the paper include Swarnagowri Vaidyanathan, Kumuditha M Weerakoon-Ratnayake, Franklin I Uba, Bo Hu, David Kaufman, Junseo Choi, Sunggook Park, and Steven...
Paper Published and Featured on Cover of EVCNA
A paper by CBM2 researchers titled, “Isolation and Analysis Methods of Extracellular Vesicles (EVs)” was published in the journal Extracellular Vesicles and Circulating Nucleic Acids in March 2021. It was also featured on the front cover of the journal. Authors of this paper include Zheng Zhao, Harshani Wijerathne, Andrew K. ...
Steve Soper Gives Keynote Presentation at SelectBio Innovations in Microfluidics and Single Cell Analysis conference
Prof. Steve Soper gave a keynote presentation on March 18, 2021, at the SelectBio Innovations in Microfluidics and Single Cell Analysis conference. His talk was titled “Affinity Selection and Enumeration of SARS-CoV-2 Viral Particles from Saliva Samples using Microfluidics for COVID-19 Diagnostics.”...
Chathurika Rathnayaka Presents Poster at PITTCON Conference & Expo 2021 Virtual Event
Chathurika Rathnayaka, a Graduate Student in the Soper research group at the University of Kansas, presented a poster titled, “Electrokinetics of Ribonucleotide Monophosphates (rNMPs) in Thermoplastic Nanochannels,” at the 2021 PITTCON Virtual Event. Chathurika’s poster presentation was during the Monday, March 8, 2021 session number PACS-11 from 8:30 AM –...
Soper to Present at PITTCON Conference & Expo 2021
Prof. Soper Gives Keynote Presentation at SelectBio Circulating Biomarkers 2021 Conference
Prof. Steven A. Soper, Director of CBM2, gave a keynote presentation February 26, 2021, at the SelectBio Circulating Biomarkers Digital Conference. His talk was titled, “Repurposing Microfluidic Tools for the Analysis of Liquid Biopsy Markers for COVID-19 Diagnostics.”...
Prof. Godwin Speaks at Kansas City VA Life Science Seminar
CBM2 faculty member Andrew Godwin, Ph.D., spoke on February 18, 2021 at the Kansas City VA Life Science Seminar, hosted by the Kansas City VA Medical Center Research Division and Midwest Biomedical Research Foundation for Veterans. Godwin, who is the Chancellor’s Distinguished Chair in Biomedical Sciences, the Deputy Director of...
New Papers Accepted for CBM2 Researchers
CBM2 researchers from the University of Kansas and Louisiana State University have two new papers accepted for publication in January 2021. ...
CBM2 Researcher Takes Position at AstraZeneca
Zheng Zhao, CBM2 graduate student in the Soper research group at the University of Kansas, graduated in December 2020 and has accepted a Postdoctoral position at AstraZeneca headquarters in Gaithersburg, MD. He is currently in the department of Translational Medicine/Oncology/Research & Development, performing research on proteomics of Extracellular Vesicles (EVs)...
Special Issue of Cells Accepting Manuscript Submissions
Dr. Malgorzata (Maggie) Witek, Associate Research Professor in the chemistry department at the University of Kansas, and CBM2 faculty member, will be guest editing a Special Issue of the journal Cells in 2021. The title of the Special Issue is “Microfluidics and Miniaturized Systems Aiding Studies Involving Cells and Animal...
Cancer Research Delayed Due to Pandemic Shutdown
While research on the disease caused by the novel coronavirus has been on a fast track the past several months, most other medical research ground to a halt in March and has yet to resume at anything near its pre-COVID pace. It is impossible to know the full implications of...
CBM2 Participates in 2020 Virtual KU Carnival of Chemistry
Due to the COVID-19 pandemic, the 2020 KU Carnival of Chemistry was held online on Saturday, October 24, 2020. The free event, hosted on Facebook by the University of Kansas Chemistry Club, provided new content and videos hourly throughout the afternoon. ...
CBM2 Makes Headlines for Developing COVID-19 Test
Center director Prof. Steven A. Soper and his research team at the University of Kansas have received grant funding from the National Institutes of Health RADx program to develop a new at-home rapid COVID-19 test, which will yield results in about 15 minutes. The test consists of a small plastic...
Electrophoresis Front Cover
The cover picture shows a single-stranded DNA molecule moving electrokinetically through a nanochannel (100 x 100 nm, width x depth) made from the plastic poly(methylmetharcylate), PMMA, and detected using laser-induced fluorescence. The separation, which is scale-dependent, is based on a combination of electrophoresis and chromatography – open tubular nano-electrochromatography (OTNEC). ...
CBM2 Publishes Paper in Journal of Colloid and Interface Science
Researchers from CBM2, led by Prof. Michael C. Murphy of Louisiana State University, recently published a paper in Volume 574 of the Journal of Colloid and Interface Science titled, “Robust, transparent, superhydrophobic coatings using novel hydrophobic/hydrophilic dual-sized silica particles.” Authors on the paper are Xiaoxiao Zhao, Daniel S. Park, Junseo...
Panel Composes "Liquid Biopsy" White Paper
Prof. Steven Soper was part of a panel (supported by Cambridge Consultants) that composed a white paper entitled “Liquid Biopsy: Current and Future Utility.”...
Prof. Andrew Godwin Participates in COVID-19 Testing
One of CBM2’s faculty members, Prof. Andrew Godwin, has been spending time this spring participating in COVID-19 testing in the Kansas City area. Dr. Godwin, deputy director of the KU Cancer Center and professor and director of molecular oncology in the department of pathology and laboratory medicine at the KU...